Carregant...
MUTYH as an Emerging Predictive Biomarker in Ovarian Cancer
Approximately 18% of ovarian cancers have an underlying genetic predisposition and many of the genetic alterations have become intervention and therapy targets. Although mutations in MutY homolog (MUTYH) are best known for MUTYH associated polyposis and colorectal cancer, it plays a role in the deve...
Guardat en:
| Publicat a: | Diagnostics (Basel) |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7825630/ https://ncbi.nlm.nih.gov/pubmed/33419231 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diagnostics11010084 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|